- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
Research at a glance
Top areas of exploration
- Mycobacterium tuberculosis , 21 publications
- Antitubercular Agents , 20 publications
- COVID-19 , 18 publications
- Tuberculosis, Pulmonary , 15 publications
Research activity
Active clinical trials
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
My publications
Filter publications
235 publications
2020
Improving survival outcome among elderly lung transplant recipients.
European journal of internal medicine
PubMed • Publisher's site2020
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Science (New York, N.Y.)
PubMed • Publisher's site2020
Lack of tocilizumab effect on mortality in COVID19 patients
Scientific Reports
PubMed • Publisher's site2020
Management of crash and burn patients with SARS-CoV-2 associated ARDS.
Journal of cardiac surgery
PubMed • Publisher's site2020
Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study.
European respiratory review : an official journal of the European Respiratory Society
PubMed • Publisher's site